Author Claim Review

 Quick Explanation Copied

 Long Explanation

Author Review: Peng Wang

Central finding: this author profile cannot be validly assessed as a single scientist. The supplied citation profile (h-index 9, 283 total citations, 48 papers, no listed affiliation) attaches to a body of work dominated by Silurian shale organic-matter enrichment, Ordos/Sichuan Basin reservoir characterization, network pharmacology of traditional formulas (Qi-Hong-Tang-Zu, Sanhua decoction, lotus leaf, rhubarb reviews), and even Chinese-language ENT clinical case series — a coherent mid-career geology/pharmacology profile typical of a Chinese university researcher Author citation profile. By contrast, the supplied evidence records — NuGraph connectomics, mouse ENS single-cell atlases, IRF7 macrophage biology in rheumatoid arthritis, MIDAS protein engineering in mammalian cells, V1 saliency EEG, Pt–CeO₂ catalysts, AQPSO conformal antennas, PRISM CADD, and novel yeast taxonomy — span at least eight unrelated fields and are almost certainly products of multiple distinct "Peng Wang" authors, the 4th–5th most common name in scientific publishing. Any score below is therefore a score over a conflated corpus, not a person.

What the record set does show (methodological quality)

Judged purely on the papers themselves, several are strong: NuGraph reports a controlled benchmark (NucEMFix: 106,978 FAFB nuclei, 7,301 error-affected; 77,475 MICrONS nuclei, 757 error-affected) where it achieves F1 = 87.99 vs nnU-Net 79.41, U-Net 76.79, StarDist 73.13, Cellpose 48.58, with ablations (backbone, SDF refinement, stage-wise) and open code/data NuGraph nucleus segmentation benchmark. The mouse ENS atlas (83,555 cells; 10 gastric, 15 small-intestinal, 17 colonic neuron subtypes; ex vivo calcium imaging of 1,700 neurons across 13 stimuli with Chat conditional knockouts) is similarly rigorous, though with acknowledged reporter-line and ex vivo blind spots Mouse ENS single-cell atlas. Weaker entries include a single-case Takotsubo report (n=1, no controlled comparison) Takotsubo case report and a materials paper whose hyperthermia claims lack any in vivo or cytotoxicity data and rest on a single AMF configuration Bi-doped LSMO hyperthermia nanoparticles.

Key blind spots and what would change this assessment

(1) Homonym conflation is the dominant error source here; OpenAlex disambiguation failed (429 rate-limit), so citation metrics cannot be assigned to any specific Peng Wang. (2) Name-similarity bias: the profile's paper list shows career discontinuity (shale geology → TCM pharmacology), which is itself evidence of at least two merged profiles. (3) Positive-result and small-n bias in the weakest entries (single case report; one in vivo biological replicate in MIDAS mouse experiments MIDAS protein engineering platform). (4) Domain asymmetry: the geology/pharmacology papers in the actual profile (h-index 9) are modest-impact applied work, whereas the strongest methodological records likely belong to other, higher-profile Wangs. This review would change substantially with verified ORCID-resolved disambiguation, per-author citation trajectories, and first/corresponding-author position data.

 BGPT Author Review

Scientific Quality

The resolved profile (h-index 9, 283 citations, 48 papers) describes a competent applied geology/pharmacology researcher, not a high-impact scientific leader. The most methodologically impressive records (NuGraph, ENS atlas, MIDAS) almost certainly belong to other homonymous authors, so attributing their excellence to this profile would be a conflation error. Score reflects the verified-profile evidence: mid-tier, applied, incremental work with some re-analysis and review-heavy output.

Communication Quality

Titles are clear and descriptive across the profile; Chinese-language clinical papers suggest local-language communication. No evidence of broad scientific writing reach; many papers appear in specialty venues. Cannot assess figures/clarity directly from abstract-level records.

Author Novelty

If judged on the verified profile, novelty is moderate: incremental applications of network pharmacology and routine sedimentary-geochemistry case studies. The genuinely novel records (NuGraph, positional TFBS grammar, PRISM, MIDAS) cannot be attributed to this author given the homonym problem.

Scientific Rigor

Verified-profile work uses established but low-risk methods (network pharmacology, basin characterization) with limited falsification emphasis. Within the record set, rigor varies widely: strong benchmarks with ablations and open code (NuGraph, PRISM, ENS atlas) versus single-case reports and materials studies lacking in vivo controls — again confounded by author ambiguity.